| Literature DB >> 29911198 |
Shiwen Wu1, Zhen Fan1,2, Youli Xiao1,2,3.
Abstract
Qian ceng Ta, the whole plant of Huperzia serrata, is an important landscape and medicinal herbs and contains abundant bioactive lycopodium alkaloids. Although the structures of more than 100 lycopodium alkaloids in Huperzia serrata have been isolated and identified, the content and distribution of these alkaloids in different tissues are still unclear. In current study, an ultra-performance liquid chromatography-mass spectrometry based comprehensive metabolomics strategy was developed, including the extraction, separation, identification, and statistical analysis. The results showed that different types lycopodium alkaloids could be separated at different time-windows, which was helpful for further metabolite identification. Peak4388 and peak3954 were metabolite biomarkers for the different tissues according to the principle component analysis and partial least squares-discriminant analysis model. A computational tool based in-house database was also built up and used for putative identification. Of the 2354 true peaks after four-step filtration, 118 peaks were putatively identified as lycopodium alkaloids by using in-house database, and four of which was identified by authentic standards. Alternatively, another computational software was used to predict the fragmentation pattern, to dereplicate the structure of identified peaks, and identified the peak3585 to N-methylhuperzine A. The integration of both computational tools could be used for more metabolites identification.Entities:
Keywords: CAO, copper amine oxidase; Different tissues; HPLC-MS, high-performance liquid chromatography-mass spectrometry; HupA, huperzine A; HupB, huperzine B; Huperzia serrata; IS, internal standard; In-silico fragmentations prediction; L/ODC, Lysine/Ornithine decarboxylase; Lycop C, lycoposerramine C; Lycop D, lycoposerramine D; Metabolite identification; Metabolomics; PCA, principle component analysis; PLS-DA, partial least squares-discriminant analysis; UPLC-MS, ultra-performance liquid chromatography-mass spectrometry; m/z, mass over charge; tR, retention time
Year: 2017 PMID: 29911198 PMCID: PMC5884255 DOI: 10.1016/j.synbio.2017.12.003
Source DB: PubMed Journal: Synth Syst Biotechnol ISSN: 2405-805X
Fig. 1The strategy of LC-MS-based comprehensive metabolomics analysis. The four-step filtration was carried out as described [21].
Fig. 2Metabolite profiling of lycopodium alkaloids in leaf, stem, and root. (A) Total ion chromatography map of the lycopodium alkaloids in different tissues. (B) plot view of the peaks was processed by the software of MS-DIAL [20]. (C) Magnified plot view of (B) to showed the labeled plot. tR ranged from 4.2 min to 5.3 min, and m/z value ranged from 220 Da to 270 Da. The plot labeled with black circle was HupA that was subsequently identified by chemical standard as shown in Fig. 3A.
Fig. 3Extracted ion maps (EIC) of identified peaks by authentic standards in different tissues of H. serrata. (A) HupA at tR = 4.79 min extracted with m/z = 243.14919, peak4297 at tR = 4.54 min was also extracted with m/z = 243.14919; (B) HupB at tR = 4.37min extracted with m/z = 257.16484, peak4360 at tR = 4.91 min was also extracted with m/z = 257.16484; (C) The internal standard of caffeine at tR = 5.34 extracted with m/z = 195.08765; (D) Lycop C at tR = 4.94 min extracted with m/z = 262.18016; (E) Lycop D at tR = 5.28 min extracted with m/z = 292.19072, this metabolite perhaps not present in root or the content was lower than the limit of determination.
Fig. 4The contents of identified chemicals in different tissues. *means that significant differences between leaf and stem comparing with root (P < .05). Three biological duplicates were performed.
The value of different databases for lycopodium alkaloids identification.
| Name | KEGG | HMDB | LipidMAPS | T3DB | CCMD | MS-DIAL | in-house database |
|---|---|---|---|---|---|---|---|
| Huperzine A | No | No | No | No | No | No | Yes |
| Huperzine B | Yes | No | No | No | * | No | Yes |
| Caffeine (IS) | Yes | Yes | No | Yes | No | Yes | Yes |
| Lycoposerramine C | No | No | No | No | No | No | Yes |
| Lycoposerramine D | No | No | No | No | No | No | Yes |
No, means the metabolite was not identified by this database using m/z value and retention time.
Yes, means the metabolite could be identified by this database using m/z value and retention time; *, means that the metabolite could be identified by m/z value but not be identified by retention time.
Putatively identified peaks by in-house database.
Fig. 5PCA and PLS-DA plots. (A) PCA score plot of different tissues; (B) PCA loading plot of different tissues; (C) PLS-DA score plot of different tissues; (D) PLS-DA loading plot of different tissues. HsRt, HsSt and HsLf means the tissues of root, stem and leaf, respectively. Three replicates were used.
Fig. 6The contents and distribution of peak4388 and peak3954 in root, stem, and leaf.
Fig. 7The Pearson correlation of identified peaks. The peaks labeled with yellow square were the identified peaks by authentic standards and two metabolite biomarkers.
Fig. 8Possible fragmentation pattern of HupA. (A) Fragmentation pattern predicted by CSI:FingerID; (B) Spectra and three predicted fragmentations of HupA.
Fig. 9Possible fragmentation pattern of HupA and peak3585. (A) Fragmentation pattern of HupA predicted by MS-FINDER; (B) Comparison between experimental spectrum and in-silico spectrum of HupA; (C) Fragmentation pattern of peak3585 predicted by MS-FINDER; (D) Comparison between experimental spectrum and in-silico spectrum of peak3585.